Increasing regulatory demands require producers to maintain strict control of all starting materials used for the synthesis of the radiopharmaceuticals.

Unfortunately, due to the size of institutions or universities producing radiopharmaceuticals, staff resources and financial means to perform these audits are limited or lacking.

The EANM has now set out to start a shared audit for PET production sites that will take the burden off the producers’ shoulders. An initiative for all European production sites out there!

Indicate your interest
More about SASAI


This website uses cookies. Learn more